GHK-Cu Research Overview (also known as Copper Peptide, GHK-Copper)
A naturally occurring copper-binding tripeptide (glycine-histidine-lysine) found in human plasma, saliva, and urine, with concentrations declining significantly with age. The fastest-growing peptide search term of 2026. Studied for collagen synthesis stimulation, wound repair acceleration, anti-inflammatory gene expression modulation, hair follicle support, and skin texture improvement.
What Is GHK-Cu?
GHK-Cu (Glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine — circulating at approximately 200 ng/mL in young adults and declining to near-undetectable levels in the elderly. First characterized by Loren Pickart in the 1970s, GHK-Cu has one of the most diverse biological activity profiles of any peptide in current research.
Wound Healing and Tissue Repair
GHK-Cu dramatically accelerates wound healing through multiple mechanisms: it promotes fibroblast and endothelial cell migration into wound sites, stimulates synthesis of collagen, elastin, and glycosaminoglycans, and increases expression of VEGF and FGF — key angiogenic factors required for new blood vessel formation in healing tissue.
Anti-Aging Skin Research
In the skin, GHK-Cu reverses many molecular signatures of aging: it upregulates genes encoding structural proteins (collagen, elastin) while downregulating matrix metalloproteinases that degrade the extracellular matrix. Clinical studies of topical GHK-Cu application demonstrate reduction in fine lines, improved skin density and firmness, and increased skin thickness. Genome-wide analysis has shown GHK-Cu modulates the expression of over 4,000 human genes — resetting many aging-associated gene expression patterns toward younger profiles.
Quick Reference
| Literature-Reported Dose Range | 1–3 mg daily |
| Literature-Reported Frequency | 1x daily |
| Literature-Reported Cycle Length | 8-12 weeks |
| Literature-Reported Washout | 4-6 weeks |
| Storage | Fridge 2-8°C, use within 30 days |
| Sites Reported in Studies | SubQ: belly, thigh, arm |
| Timing | Morning or evening |
Research Indications
Skin Regeneration
Collagen Synthesis
Increases type I and III collagen production for improved skin firmness and reduced wrinkle depth
Wound Healing
Accelerates closure of acute wounds and chronic ulcers with enhanced cellular migration and proliferation
Anti-Aging Effects
Reduces fine lines and age spots while improving overall skin texture and elasticity
Hair Growth
Follicle Stimulation
Promotes hair follicle enlargement and extends the anagen (growth) phase for thicker hair
Scalp Health
Improves circulation and reduces scalp inflammation for optimal hair growth conditions
Hair Thickness
Increases hair shaft diameter and overall density over 12-16 weeks of consistent use
Anti-Inflammatory
Immune Modulation
Regulates inflammatory cytokine production and promotes balanced immune responses
Tissue Protection
Protects tissues from oxidative stress and inflammatory damage through antioxidant mechanisms
Healing Enhancement
Reduces excessive inflammation while maintaining beneficial inflammatory responses for healing
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Anti-aging/Skin health | 1–3 mg daily | 1x daily | SubQ |
| Hair growth stimulation | 2-3mg | 1x daily | SubQ |
| Wound healing | 1–3 mg daily | 2x daily | SubQ near affected area |
| General wellness | 1mg | 1x daily | SubQ |
Timing
Recommended administration window: morning or evening. Typical onset: 2-4 weeks for skin, 4-8 weeks for hair.
Peptide Interactions
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
This pairing includes GH/IGF-axis signaling. Published evidence for the exact combination is limited; define exposure timing and monitor protocol-relevant endocrine and tolerability endpoints rather than assuming additive benefit.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
The components have different research mechanisms and may be scheduled around training, feeding, or metabolic assessments. Evidence for the exact combination is limited, so timing should be documented to avoid confounding endpoint interpretation.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
This pairing includes GH/IGF-axis signaling. Published evidence for the exact combination is limited; define exposure timing and monitor protocol-relevant endocrine and tolerability endpoints rather than assuming additive benefit.
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
Both affect melanin production, monitor for skin discoloration
Risk of copper toxicity when combined with additional copper sources
Growth hormone effects may complement collagen synthesis
May interfere with copper binding and peptide effectiveness
Reported Research Timeline
01Week 1–2 (reported in cited studies): improved skin texture and hydration
02Week 3–4 (reported in cited studies): reduction in fine lines and wrinkles
03Week 6–8 (reported in cited studies): enhanced skin firmness and elasticity
04Week 8–12 (reported in cited studies): comprehensive anti-aging effects
05Hair growth: 4-8 weeks for initial results
Zinc Supplementation (>25 mg/day)
Caution AdvisedHigh-dose zinc competes with copper for intestinal absorption and binding sites. Users taking zinc supplements concurrently should keep zinc below 25 mg elemental zinc per day to avoid impairing GHK-Cu's activity.
Complementary healing stack — BPC-157 promotes angiogenesis and tissue repair while GHK-Cu drives collagen synthesis and remodeling. Widely used together in healing and anti-aging protocols.
Wilson's Disease / Copper-Chelating Medications
CAUTION — NOT RECOMMENDEDAbsolutely contraindicated in Wilson's disease (impaired copper metabolism). Copper-chelating medications (penicillamine, trientine) will work against GHK-Cu's copper delivery mechanism — do not combine.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Monitor injection sites for unusual blue discoloration
Start with lower doses to assess copper tolerance
Use sterile injection technique to prevent infection
Watch for signs of copper toxicity (nausea, metallic taste)
Avoid excessive copper supplementation from other sources
Seek Medical Attention If:
Severe skin discoloration or persistent staining
Persistent metallic taste or nausea
Unusual fatigue or copper toxicity symptoms
Injection site infections or necrosis
Allergic reactions (rash, swelling, difficulty breathing)
Wilson's disease is an absolute contraindication. Wilson's disease causes impaired copper metabolism — injectable copper peptide is dangerous in this population and could precipitate a copper toxicity crisis.
Do not exceed 10 mg/day total copper from all sources (GHK-Cu injections + dietary copper + supplements). Monitor for signs of copper excess: nausea, abdominal pain, unusual fatigue, or blue-green tinge at injection sites.
Avoid during pregnancy without medical supervision. Copper metabolism is tightly regulated during pregnancy; disrupting it with exogenous copper peptides carries unknown fetal risk.
Quality Indicators
Verified Marker
Blue-tinted powder
Characteristic light blue color from copper content. Pure white may indicate copper deficiency
Verified Marker
Complete dissolution
Should dissolve fully in BAC water to form a clear blue solution with no particles
Verified Marker
Stable blue coloration
Maintains consistent light blue color after reconstitution without darkening
Quality Concern
Green or dark blue discoloration
Suggests oxidation or contamination - product should be discarded
Quality Concern
Persistent cloudiness
Indicates poor quality, contamination, or improper storage
Research Citations
- Regenerative and Protective Actions of GHK-Cu Peptide
Review | Int J Mol Sci | 2018 | PMC6073405 - GHK Peptide in Skin Regeneration
Review | Biomed Res Int | 2015 | PMC4508379 - GHK and DNA: Resetting the Genome to Health
Review | Biomed Res Int | 2014 | PMC4180391 - GHK-Cu in Prevention of Oxidative Stress and Aging
Review | Oxid Med Cell Longev | 2012 | PMC3359723 - Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective
Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR, 2025, Bioimpacts - Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians
Mayfield CK, Bolia IK, Feingold CL, 2026, Am J Sports Med - An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant
Hu D, Zhang X, Gong S, 2025, Colloids Surf B Biointerfaces - Enhanced biological properties of collagen/chitosan-coated poly(ε-caprolactone) scaffold by surface modification with GHK-Cu peptide and 58S bioglass
Molavi AM, Sadeghi-Avalshahr A, Nokhasteh S, 2020, Prog Biomater - Polyaspartic acid, 2-acrylamido-2-Methyl propane sulfonic acid and sodium alginate based biocompatible stimuli responsive polymer gel for controlled release of GHK-Cu peptide for wound healing
Sharma S, Anwar MF, Dinda AK, 2022, J Biomater Appl
"
Research Focus
Wound healing, Collagen synthesis, Anti-aging, Skin regeneration, Anti-inflammatory, Hair growth
Verified Vendors Carrying GHK-Cu
Frequently Asked Questions
What should researchers watch for with GHK-Cu?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with GHK-Cu?
Week 1–2 (reported in cited studies): improved skin texture and hydration
How is GHK-Cu typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →